Adient (ADNT) EBITDA (2016 - 2025)
Historic EBITDA for Adient (ADNT) over the last 11 years, with Q4 2025 value amounting to $90.0 million.
- Adient's EBITDA fell 322.58% to $90.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $112.0 million, marking a year-over-year decrease of 6553.85%. This contributed to the annual value of $115.0 million for FY2025, which is 6647.23% down from last year.
- Adient's EBITDA amounted to $90.0 million in Q4 2025, which was down 322.58% from $120.0 million recorded in Q3 2025.
- Adient's EBITDA's 5-year high stood at $1.2 billion during Q3 2021, with a 5-year trough of -$216.0 million in Q1 2025.
- Over the past 5 years, Adient's median EBITDA value was $103.5 million (recorded in 2023), while the average stood at $138.7 million.
- In the last 5 years, Adient's EBITDA skyrocketed by 224000.0% in 2021 and then crashed by 280000.0% in 2025.
- Adient's EBITDA (Quarter) stood at $40.0 million in 2021, then skyrocketed by 185.0% to $114.0 million in 2022, then fell by 2.63% to $111.0 million in 2023, then fell by 16.22% to $93.0 million in 2024, then dropped by 3.23% to $90.0 million in 2025.
- Its EBITDA stands at $90.0 million for Q4 2025, versus $120.0 million for Q3 2025 and $118.0 million for Q2 2025.